New data presented last week at the annual Transcatheter Cardiovascular Therapies meeting showed Boston Scienfitic's Watchman anti-stoke device to be comparable to treatment with the anti-coagulant warfarin.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/XOV83f
Cap comentari:
Publica un comentari a l'entrada